Full Press Release Details
Indivior To Participate in Upcoming Investor Events
Slough, UK, and Richmond, VA, May 16, 2024 - Indivior PLC (LSE/NASDAQ: INDV) today announced
that it will participate in the following investor
Craig-Hallum Institutional Investor Conference - Minneapolis,
Indivior Management will host 1x1 / Group meetings
on Wednesday May 29th,
2024. Interested investors should contact their Craig-Hallum
representative to schedule a meeting.
Jefferies Global Healthcare
Conference - New York City, NY
Mark Crossley, Chief Executive Officer, will host
a presentation on Wednesday June 5th,
2024 at 8:30 a.m. US EST. The presentation will be publicly
available and can be viewed using the following
Indivior is a global pharmaceutical company working to help change
patients' lives by developing medicines to treat substance use
disorders (SUD) and serious mental illnesses. Our vision is that
all patients around the world will have access to evidence-based
treatment for the chronic conditions and co-occurring disorders of
SUD. Indivior is dedicated to transforming SUD from a global human
crisis to a recognized and treated chronic disease. Building on its
global portfolio of opioid use disorder treatments, Indivior has a
pipeline of product candidates designed to both expand on its
heritage in this category and potentially address other chronic
conditions and cooccurring disorders of SUD. Headquartered in the
United States in Richmond, VA, Indivior employs more than 1,100
individuals globally and its portfolio of products is available in
37 countries worldwide. Visit www.indivior.com to learn
more. Connect with Indivior on LinkedIn by
visiting www.linkedin.com/company/indivior.
Vice President, Investor Relations
Tel: 804-402-7123 or jason.thompson@indivior.com
Director, Investor Relations
Tel: 804-263-3978 or timothy.owens@indivior.com